Steven D. Rubin
Sits on 6 boards. Overboarded · 6 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 6
- Current seats
- 6
- Board service
- 17 years
- Director since
- 2023
17 years of board service in total across 6 boards, counting each seat separately. Longest: Eloxx Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cocrystal Pharma Inc. July 14, 202690.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | Entera Bio Ltd. | Grant or award | +19,117 | — | — |
| Jul 24, 2026 | OPKO Health Inc. | Shares withheld for tax | −53,266 | $1.22 | $64,985 |
| Jun 4, 2026 | Red Violet Inc. | Grant or award | +2,179 | — | — |
| Feb 12, 2026 | Entera Bio Ltd. | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Feb 9, 2026 | Entera Bio Ltd. | Open-market purchase | +10,000 | $1.20 | $12,000 |
| Jan 24, 2026 | Eloxx Pharmaceuticals Inc. | Option exercise | +1,875 | — | — |
| Dec 19, 2025 | Red Violet Inc. | Grant or award | +4,450 | — | — |
| Mar 19, 2025 | Red Violet Inc. | Open-market sale | −10,000 | $38.93 | $389,300 |
| Jan 24, 2025 | Eloxx Pharmaceuticals Inc. | Option exercise | +3,750 | — | — |
| Nov 4, 2024 | Red Violet Inc. | Grant or award | +8,000 | — | — |
| Oct 16, 2024 | Eloxx Pharmaceuticals Inc. | Grant or award | +12,000 | — | — |
| Oct 9, 2024 | Cocrystal Pharma Inc. | Grant or award | +18,957 | — | — |
| Jul 24, 2024 | OPKO Health Inc. | Grant or award | +437,500 | — | — |
| Jan 5, 2024 | OPKO Health Inc. | Open-market purchase | +10,000 | $0.87 | $8,700 |
| Nov 30, 2023 | Red Violet Inc. | Grant or award | +10,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.